Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now

US govt awards $1.4 billion for development of new COVID therapies, vaccines

Published Aug 22, 2023 03:44PM ET Updated Aug 22, 2023 05:01PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid/File Photo
 
REGN
+1.26%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

(Reuters) - The U.S. government said on Tuesday it had awarded $1.4 billion for the development of new therapies and vaccines against COVID-19, including a $326 million contract with Regeneron (NASDAQ:REGN) Pharmaceuticals for a next-generation antibody therapy for prevention of infections.

The funding to Regeneron is a part of a $5 billion initiative dubbed "Project NextGen" by the U.S. Department of Health and Human Services (HHS).

Regeneron had earlier developed a monoclonal antibody therapy against COVID, which was authorized by the U.S. Food and Drug Administration in November 2020, but its use was limited early last year after it was found to be unlikely to work against the Omicron variant.

The funding also includes $1 billion for four mid-stage clinical trials of new COVID vaccines, and $100 million to Global Health Investment Corp - a non-profit organization that invests in new technologies that will accelerate responses to diseases.

US govt awards $1.4 billion for development of new COVID therapies, vaccines
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (4)
Max Boutelle
Max Boutelle Aug 22, 2023 5:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just what we need🙄  How about sending some of that $ to Maui.
Mark Gesswein
Mark Gesswein Aug 22, 2023 4:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Basically an admission that the CURRENT covid ‘vaccines’ are useless and worthless. But, we knew that already. After the last debacle, no one is putting anything for covid into theit bodies. There will be no masking, nor shutdown, should covid ‘pop up’ again. No one will comply, not even those on the Left. That ship has sailed.
Brad Albright
Brad Albright Aug 22, 2023 4:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah, because viruses don't mutate. Thank you Dr. Gesswein.
Max Boutelle
Max Boutelle Aug 22, 2023 4:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes Mark, useless, worthless but you left out unsafe.  "Safe and effective" they said, "two weeks" they said...
dylan mulvaney
dylan mulvaney Aug 22, 2023 4:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In real news, the WHO now acknowledges the use of Ivermectin for COVID treatment. Remember how they called it "horse pills." We have e-mails from criminal Fauci revealing he knew it worked, but only said it didn't because it would cause the vaccines to no longer have emergency use authorization, which they needed because the vaccines do not have safety data to authorize their use legitimately.
Jake Vee
Jake Vee Aug 22, 2023 4:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I didn’t hear about the WHO, but I’m not surprised because the FDA said the same thing.
Boyan Davidov
Boyan Davidov Aug 22, 2023 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
work on new variants first then on the therapy
Mark Gesswein
Mark Gesswein Aug 22, 2023 3:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
These ‘therapies’ ARE for the new variants. The ones you haven’t heard abaout yet, but will shortly. It’s election season, so the Dems will have to pull the covid card out of their bag of tricks again soon.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email